Artelo Biosciences, Inc. (ARTL)
7.29
+0.68
(+10.29%)
USD |
NASDAQ |
Apr 07, 16:00
7.32
+0.03
(+0.41%)
After-Hours: 20:00
Artelo Biosciences SG&A Expense (TTM) : 5.981M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 82.26M |
| GlucoTrack, Inc. | 6.277M |
| Ovid Therapeutics, Inc. | 24.11M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| Gossamer Bio, Inc. | 37.63M |